Clinical Trial Update: 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating 0.8% disodium salt solution as an aid for ureteral patency in ureter injury; completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureter Injury

Drugs mentioned

• 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution

Snippet

Sponsor: Prove pharm | Conditions: Ureter Injury | Phase 3 | Status: COMPLETED | Results posted: 2022-11-30